carbamazepine has been researched along with Parkinson Disease, Secondary in 7 studies
Carbamazepine: A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.
carbamazepine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant.
Parkinson Disease, Secondary: Conditions which feature clinical manifestations resembling primary Parkinson disease that are caused by a known or suspected condition. Examples include parkinsonism caused by vascular injury, drugs, trauma, toxin exposure, neoplasms, infections and degenerative or hereditary conditions. Clinical features may include bradykinesia, rigidity, parkinsonian gait, and masked facies. In general, tremor is less prominent in secondary parkinsonism than in the primary form. (From Joynt, Clinical Neurology, 1998, Ch38, pp39-42)
| Excerpt | Relevance | Reference |
|---|---|---|
| " Reduction in VPA dosage in the third patient produced no improvement." | 2.71 | Reversible parkinsonism with normal beta-CIT-SPECT in patients exposed to sodium valproate. ( Clough, P; Duncan, S; Easterford, K; Fallon, K; Kellett, M, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Okuyucu, EE | 1 |
| Duman, T | 1 |
| Akcin, E | 1 |
| Easterford, K | 1 |
| Clough, P | 1 |
| Kellett, M | 1 |
| Fallon, K | 1 |
| Duncan, S | 1 |
| Froomes, PR | 1 |
| Stewart, MR | 1 |
| Touw, DJ | 2 |
| Gernaat, HB | 2 |
| van der Woude, J | 1 |
| Van de Woude, J | 1 |
| Chouinard, G | 1 |
| Goñi, M | 1 |
| Jimenez, M | 1 |
| Feijoo, M | 1 |
2 trials available for carbamazepine and Parkinson Disease, Secondary
| Article | Year |
|---|---|
Reversible parkinsonism with normal beta-CIT-SPECT in patients exposed to sodium valproate.
Topics: Adult; Aged; Anticonvulsants; Carbamazepine; Epilepsy; Female; Humans; Incidence; Male; Middle Aged; | 2004 |
The use of benzodiazepines in the treatment of manic-depressive illness.
Topics: Acute Disease; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Basal Ga | 1988 |
5 other studies available for carbamazepine and Parkinson Disease, Secondary
| Article | Year |
|---|---|
Reversible parkinsonism with oxcarbazepine use.
Topics: Adult; Anticonvulsants; Carbamazepine; Female; Humans; Oxcarbazepine; Parkinson Disease, Secondary | 2009 |
A reversible parkinsonian syndrome and hepatotoxcity following addition of carbamazepine to sodium valproate.
Topics: Aged; Carbamazepine; Chemical and Drug Induced Liver Injury; Cholestasis; Drug Interactions; Drug Th | 1994 |
[Parkinsonism following addition of fluoxetine to the treatment with neuroleptics or carbamazepine].
Topics: Adult; Aged; Antipsychotic Agents; Carbamazepine; Dopamine Antagonists; Drug Interactions; Female; F | 1992 |
Fluoxetine and parkinsonism in patients taking carbamazepine.
Topics: Aged; Bipolar Disorder; Carbamazepine; Drug Interactions; Drug Therapy, Combination; Female; Fluoxet | 1991 |
Parkinsonism induced by phenytoin.
Topics: Aged; Carbamazepine; Gait; Humans; Male; Parkinson Disease, Secondary; Phenytoin | 1985 |